Top Suppliers:I want be here

81864-47-3

81864-47-3 structure
81864-47-3 structure

Name 1,3,6,7-tetrahydro-[1,4]dioxino[2,3-f]benzimidazole-2-thione
Synonyms HMS547L07
6,7-dihydro-1H-[1,4]dioxino[2,3-f]benzimidazole-2-thiol
6,7-dihydro-1H-[1,4]dioxino[2',3':4,5]benzo[d]imidazole-2-thiol
2-mercapto-6,7-dihydro-1H-[1,4]dioxino[2,3-f]benzoimidazole
Density 1.55g/cm3
Boiling Point 352.3ºC at 760 mmHg
Melting Point 300ºC
Molecular Formula C9H8N2O2S
Molecular Weight 208.23700
Flash Point 166.9ºC
Exact Mass 208.03100
PSA 85.94000
LogP 1.62280
Index of Refraction 1.748
Name: 6 7-Dihydro-1H-[1 4]dioxino[2 3 :4 5]benzo[d]imidazole-2-thiol 97% Material Safety Data Sheet
Synonym: 5,6-Ethylenedioxy-2-mercaptobenzimidazol
CAS: 81864-47-3
Section 1 - Chemical Product MSDS Name:6 7-Dihydro-1H-[1 4]dioxino[2 3 :4 5]benzo[d]imidazole-2-thiol 97% Material Safety Data Sheet
Synonym:5,6-Ethylenedioxy-2-mercaptobenzimidazol

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
81864-47-3 6,7-Dihydro-1H-[1,4]dioxino[2',3':4,5] 97% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 81864-47-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: > 300 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H8N2O2S
Molecular Weight: 208

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 81864-47-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
6,7-Dihydro-1H-[1,4]dioxino[2',3':4,5]benzo[d]imidazole-2-thiol - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 81864-47-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 81864-47-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 81864-47-3 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A
HS Code 2934999090

~69%

81864-47-3 structure

81864-47-3

Literature: Xuanzhu Pharma Co., Ltd. Patent: EP2532665 A1, 2012 ; Location in patent: Page/Page column 30 ;

~%

81864-47-3 structure

81864-47-3

Literature: EP2532665 A1, ;

~%

81864-47-3 structure

81864-47-3

Literature: EP2532665 A1, ;

~%

81864-47-3 structure

81864-47-3

Literature: EP2532665 A1, ;

~%

81864-47-3 structure

81864-47-3

Literature: EP2532665 A1, ;
HS Code 2934999090
Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%